Skip to main content
. 2021 Jun 8;92(10):1080–1088. doi: 10.1136/jnnp-2020-325815

Figure 3.

Figure 3

Time to regain full muscle strength in mild GBS patients treated with supportive care versus IVIg in the complete cohort (A) and in the subgroup with persistently mild GBS patients (B). GBS, Guillain-Barré syndrome; IVIg, intravenous immunoglobulin.